Skip to main content
Caplight Logo









LanthaGen Bio

LanthaGen Bio

Private
ManchesterEnergy & Sustainabilityhttps://www.lanthagenbio.co.uk/

Last Round

Pre Seed

May 1, 2026

Total Funding Raised

$1.72M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

LanthaGen Bio is a biotechnology company that develops synthetic biology-based systems for the selective extraction and recovery of rare earth and precious metals from industrial waste streams.

Sector

Energy & Sustainability

Verticals

Biotechnology, Circular Economy, Waste Management

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologyrare earth recoverymetal extractionbiominingcircular economye-waste recyclingengineered proteinsprotein engineeringurban miningmolecular dynamicsindustrial waste managementbiotech startupclean techdeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LanthaGen Bio Comparables

Compare LanthaGen Bio with similar companies based on industry and business-model similarity.

LanthaGen Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CaptuREE
89%
RareTerra
88%
Infinite Elements, Inc.
85%

LanthaGen Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 1, 2026
GrantDec 1, 2025
GrantJul 14, 2025

Key People

Founding team and executive leadership

Ellie Goulding

Co-founder & CTO

Founding Team

Dan Healy

CEO & Co-Founder

Founding Team

Sahara Bhanot

CEO and Co-founder

Founding Team

LanthaGen Bio Investors

Notable investors and investment history

LanthaGen Bio investors
InvestorRounds
The University of ManchesterGrant
SPRINDGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    Completed a Pre Seed funding round.

  • Dec 1, 2025

    $1.62M grant received from SPRIND.

LanthaGen Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LanthaGen Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LanthaGen Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester
Employee Range5
Year Founded2025
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?